highperformr logo

Psomagen's Overview

Total employees130
HeadquartersRockville
Founded2004

Psomagen is a US-based genomics company, spun off from Macrogen, providing comprehensive genomic sequencing and bioinformatics services. They cater to the research, academic, pharmaceutical, and clinical sectors with services including next-generation sequencing (NGS), Sanger sequencing, CES services, and bioinformatics analysis. Psomagen operates CLIA-certified and CAP-accredited laboratories, emphasizing high-quality data and tailored solutions for diverse applications like genetic research, drug discovery, and diagnostics. They aim to advance precision medicine and life sciences through cutting-edge genomic technologies and expertise.

Where is Psomagen's Headquarters?

HQ Function

Serves as the main operational hub, housing corporate leadership, research and development, CLIA-certified and CAP-accredited sequencing laboratories, and customer support.

Notable Features:

State-of-the-art laboratory facilities equipped for high-throughput sequencing and advanced bioinformatics. Located within the I-270 Technology Corridor, a prominent biotech hub.

Work Culture:

A scientifically driven and innovative environment, focusing on precision, quality, and collaboration to meet the complex needs of its diverse clientele in the life sciences.

HQ Significance:

Strategically located near key federal research institutions like the NIH and FDA, fostering collaborations and serving the dense biotech ecosystem of the Mid-Atlantic region.

Values Reflected in HQ: Commitment to scientific excellence, technological innovation, customer satisfaction, and contributing to advancements in health and life sciences.

Location:

While Psomagen's direct offices are primarily in the United States, it operates as a key part of Macrogen's global network. This connection allows Psomagen to offer its services internationally and leverage global R&D, high-throughput sequencing capabilities, and bioinformatics expertise, particularly from Macrogen's extensive facilities in South Korea and other worldwide locations. This enables support for multi-national research projects and clients across North America, Europe, and Asia.

Street Address:

1330 Piccard Drive

City:

Rockville

State/Province:

MD

Country:

USA

Psomagen's Global Presence

Cambridge, MA, USA

Address: One Broadway, 14th Floor, Cambridge, MA 02142

To provide localized support and foster collaborations within the New England life sciences cluster, one of the world's leading centers for biomedical innovation.

New York, NY, USA

Address: 135 W 41st St, New York, NY 10036

Supports business growth and client engagement in the New York region, leveraging proximity to financial institutions and research centers.

San Diego, CA, USA

Address: 6199 Cornerstone Ct. E, Ste 101, San Diego, CA 92121

To serve the significant life sciences market on the West Coast, offering accessible genomic services and fostering regional partnerships.

Seoul, South Korea

Address: 10F, 1001, World Cup Buk-ro 396, Sangam-dong, Mapo-gu, Seoul, Republic of Korea 03925

Serves as the global R&D and operational backbone, supporting Psomagen with large-scale capabilities and technological advancements originating from the parent company.

Buying Intent Signals for Psomagen

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Psomagen

As of April 2025, Psomagen' leadership includes:

Ryan W. Kim - Chief Executive Officer
JC Lee - Chief Financial Officer
Dr. Su Hong Kim-Ha - CLIA Laboratory Director / Head of Laboratory Operations
Alberto Leon - Chief Commercial Officer

Investors of Psomagen

Psomagen has been backed by several prominent investors over the years, including:

Macrogen (Parent Company)

Executive New Hires/Exits in the Last 12 Months

Hire0
Exits0

Psomagen completed its merger with a subsidiary of its parent company, Macrogen, and became a private company in January 2024. Specific executive changes related to this transition, if any beyond the existing team leading through the merger, have not been widely publicized. The core leadership team appears to have remained consistent through this period.

Technology (Tech Stack) used by Psomagen

Discover the tools Psomagen uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Psomagen Email Formats and Examples

Psomagen likely utilizes common corporate email formats. Based on publicly available information and standard practices, emails typically combine an employee's first name (or initial) and last name.

Common formats include [first].[last]@psomagen.com or [first_initial][last]@psomagen.com.

Format

ryan.kim@psomagen.com

Example

80%

Success rate

News and media

GlobeNewswireJanuary 29, 2024

Psomagen Announces Completion of Merger and Becoming a Private Company

Psomagen, Inc. today announced the successful completion of its previously announced merger with an indirect, wholly-owned subsidiary of Macrogen, Inc. As a result of the merger, Psomagen has become a private company and its common stock has ceased trading on the Nasdaq Capital Market....more

GlobeNewswireJanuary 25, 2024

Psomagen Announces Pricing of $8 Million Public Offering

Psomagen, Inc. announced the pricing of its underwritten public offering of 3,478,261 shares of its common stock at a public offering price of $2.30 per share, for gross proceeds of approximately $8.0 million, prior to its merger and delisting....more

GlobeNewswireSeptember 6, 2023

Psomagen to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Psomagen, Inc. announced that its CEO, Ryan W. Kim, and CFO, JC Lee, would present at the H.C. Wainwright 25th Annual Global Investment Conference held in September 2023, discussing the company's strategy and services....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Psomagen, are just a search away.